Research Article
Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue Sarcoma
Table 3
Registry-reported patient, tumor, and treatment characteristics.
| | N (%) |
| Total cohort | 402 (100) | Age (yrs) | <18 | 17 (4) | 18–40 | 84 (21) | 41–70 | 199 (49) | 71+ | 102 (26) | Age, mean yrs (SD) | 55 (20.1) | Sex | Male | 226 (56) | Female | 176 (44) | Race | White | 349 (87) | Black | 44 (11) | Other | 9 (2) | Insurance status | Private | 193 (48) | Medicare | 116 (29) | Medicaid | 23 (6) | Uninsured | 14 (3) | Military | 2 (1) | Unknown | 54 (13) | State of residence | Ohio | 157 (39) | Other state | 245 (61) | Histology | Undifferentiated pleomorphic sarcoma | 121 (30) | Liposarcoma | 63 (16) | Myxofibrosarcoma | 51 (13) | Synovial sarcoma | 28 (7) | Leiomyosarcoma | 26 (6) | Other | 24 (6) | Malignant peripheral nerve sheath tumor | 22 (5) | Extraskeletal bone sarcoma | 17 (4) | Rhabdomyosarcoma | 15 (4) | Dermatofibrosarcoma protuberans | 12 (3) | Angiosarcoma | 9 (2) | Round cell sarcoma | 7 (2) | Clear cell sarcoma | 7 (2) | Location | Lower extremity | 235 (58) | Upper extremity | 69 (17) | Pelvis | 38 (9) | Chest wall | 34 (9) | Trunk | 26 (7) | Grade | Grade 1 | 41 (10) | Grade 2 | 65 (16) | Grade 3 | 130 (32) | Grade 4 | 57 (14) | Unknown | 109 (28) | Stage | I | 95 (24) | II | 90 (22) | III | 116 (29) | IV | 39 (10) | Unknown | 62 (15) | Time to treatment initiation (TTI) cohorts | TTI = 0 cohort | 118 (29) | TTI >0 cohort | 284 (71) | First treatment type | Surgery | 280 (70) | Radiation | 86 (21) | Chemotherapy | 36 (9) | First treatment type by TTI cohort | TTI = 0 | 118 | Surgery | 118 (100) | TTI >0 | 284 | Surgery | 162 (57) | Radiation | 86 (30) | Chemotherapy | 36 (13) | Physician type who performed first treatment | Sarcoma physician within our health system | 192 (48) | Nonsarcoma physician within our health system | 132 (33) | Outside health system | 78 (19) |
|
|
SD = standard deviation.
|